The current study suggests that IL-31 contributes to the development of SSc in two ways: directly inducing collagen production in fibroblasts, and indirectly promoting Th2 polarization by inducing pro-Th2 cytokines in fibroblasts. Here, IL31 is linked to systemic sclerosis.